The global cannabis industry barely had time to catch its breath over the Christmas break, following several seismic developments at
A comprehensive cross-section of the world’s most influential policymakers and global regulatory officials are set to meet with a group
The increasingly blurry lines between Germany’s medical and recreational cannabis markets are continuing to cause conflict among lawmakers and industry
Bedrocan, one of Europe’s largest and longest-running suppliers of pharmaceutical and medical cannabis, has announced plans to commercialise a new high-CBD strain of cannabis, Bedrolina.
LONG-ESTABLISHED European cannabis company Bedrocan has re-entered the Canadian medical cannabis market following the purchase of a facility in Toronto.
Bedrocan, which for years has only supported external researchers financially, today announced the launching of its own Clinical Research Unit
THE Department of Health & Social Care (DHSC) has announced that emergency measures to ensure supplies of childrens’ epilepsy cannabis
DANISH patients will be able to access medical cannabis for another four years after politicians agreed to extend a nationwide
A PERMANENT solution to the import impasse on children’s epilepsy cannabis medication has emerged with the Dutch manufacturer set to
Prof Mike Barnes, one of the UK’s leading cannabis clinicians responds to suggestions that the medicines for UK children with
We won’t spam you
